Home > Healthcare > Pharmaceuticals > Pharma Manufacturing > Fill Finish Manufacturing Market

Fill Finish Manufacturing Market Share

Report ID: GMI8713
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Fill Finish Manufacturing Market Share

The fill finish manufacturing industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different technologies is among a key market strategy. Some of the leading industry players have a notable presence in the market.

Fill Finish Manufacturing Market Companies

Some of the eminent market participants operating in the fill finish manufacturing industry include:

Boehringer Ingelheim
Baxter International Inc.
Catalent, Inc.
Eurofins Scientific S.E.
Fresenius SE & Co. KGaA
MabPlex International Co., Ltd.
Novartis AG
Recro Pharma, Inc.
Recipharm
Symbiosis Pharmaceuticals Pvt. Ltd.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global fill finish manufacturing market was valued at around USD 9.7 billion in 2023 and is estimated to reach over USD 18.6 billion by 2032, as it offers advanced aseptic solutions for biopharmaceuticals, mitigating stability issues and contamination risks.

The consumables segment in the fill finish manufacturing industry is estimated to account for USD 13.6 billion by 2032, attributed to the consistency, reliability, and compatibility with filling equipment.

North America fills finish manufacturing market accounted for USD 3.9 billion in revenue in 2023, favored by the surge in technological advancements within fill finish manufacturing processes, paralleled by the flourishing biopharmaceutical industry.

Boehringer Ingelheim, Baxter International Inc., Catalent, Inc., Eurofins Scientific S.E., Fresenius SE & Co. KGaA , MabPlex International Co., Ltd., Novartis AG, Recro Pharma, Inc., Recipharm and Symbiosis Pharmaceuticals Pvt. Ltd.